 Lack efficacy tranexamic acid thrombocytopenic bleeding controlled double-blind study effect oral antifibrinolytic agent tranexamic acid patients amegakaryocytic thrombocytopenia regards need platelet transfusions number episodes patient control sequential randomized courses tranexamic acid identical placebo need platelet transfusions due total number episodes tranexamic acid placebo courses Patients platelet transfusions discretion personal physician detailed records episodes patients full study none reduction need platelet transfusions patients study reduction number episodes tranexamic acid treatment number placebo data prophylactic administration tranexamic acid dependence platelet transfusions decrease episodes patients due amegakaryocytic thrombocytopenia